Nils Lonberg

Insider Reports History

Location: Woodside, CA
Signature: /s/ Lara Meisner, Attorney-in-Fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nils Lonberg:

Form 4 holding Director

Bicara Therapeutics Inc.

Security class: Common Stock
Shares / value: 29,991
Estimated value: $397,183
Report date: 12 Sep 2024
Price: $13.24
Ownership: Direct

Form 4 holding Director

Bicara Therapeutics Inc.

Security class: Stock Option (Right to Buy)
Shares / value: 23,746
Estimated value
Report date: 09 Jun 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Nils Lonberg

4 BCAX

Bicara Therapeutics Inc.

Report period: 09 Jun 2025
Transactions: 1
Transaction value: $0
Filing time: 10 Jun 2025, 16:29
Role: Director
Next action: Open filing details

4 BCAX

Bicara Therapeutics Inc.

Report period: 12 Sep 2024
Transactions: 1
Transaction value: $0
Filing time: 16 Sep 2024, 16:42
Role: Director
Next action: Open filing details

3 BCAX

Bicara Therapeutics Inc.

Report period: 12 Sep 2024
Transactions: 0
Transaction value: $0
Filing time: 12 Sep 2024, 21:03
Role: Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .